PubRank

N Pallisgaard

Author PubWeight™ 29.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003 7.04
2 Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003 4.31
3 The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. Ann Oncol 2009 1.40
4 Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia 2013 1.27
5 Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol 1992 1.16
6 CPP1, a DNA-binding protein involved in the expression of a soybean leghemoglobin c3 gene. Proc Natl Acad Sci U S A 2000 1.04
7 KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer. Br J Cancer 2013 0.94
8 Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program. Leukemia 2004 0.94
9 Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow. Leukemia 2007 0.93
10 A new class of plant homeobox genes is expressed in specific regions of determinate symbiotic root nodules. Plant Mol Biol 1999 0.92
11 Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res 1992 0.91
12 Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 2002 0.89
13 Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol 1994 0.89
14 Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol 2002 0.88
15 Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera. Ann Hematol 2008 0.84
16 Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leuk Lymphoma 2001 0.83
17 Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia. Leukemia 2001 0.82
18 A novel type of DNA-binding protein interacts with a conserved sequence in an early nodulin ENOD12 promoter. Plant Mol Biol 1996 0.81
19 Identification and cloning of differentially expressed genes by DDRT-PCR. Methods Mol Biol 1997 0.79
20 Familial Alzheimer's disease co-segregates with a Met146I1e substitution in presenilin-1. Clin Genet 1996 0.78
21 Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet. Leukemia 2011 0.78
22 Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia. Eur J Haematol 2003 0.78
23 Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia. Semin Hematol 2000 0.75
24 [Multidisciplinary diagnostics in acute leukemia]. Ugeskr Laeger 1998 0.75
25 DNA recognition sequence determination directly on plaques of a lambda expressed recombinant DNA binding protein. Anal Biochem 1994 0.75
26 A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR method. Leukemia 1997 0.75
27 [Molecular biology in acute lymphoblastic leukemia]. Ugeskr Laeger 2001 0.75